BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma familiesSARANTAUS, Laura; AURANEN, Annika; NEVANLINNA, Heli et al.International journal of oncology. 2001, Vol 18, Num 4, pp 831-835, issn 1019-6439Article

The importance of replication in gene-gene interaction studies : multifactor dimensionality reduction applied to a two-stage breast cancer case-control studyMILNE, Roger L; FAGERHOLM, Rainer; NEVANLINNA, Heli et al.Carcinogenesis (New York. Print). 2008, Vol 29, Num 6, pp 1215-1218, issn 0143-3334, 4 p.Article

Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatmentHEIKKINEN, Tuomas; KORPELA, Taina; FAGERHOLM, Rainer et al.Breast cancer research and treatment. 2013, Vol 141, Num 1, pp 79-88, issn 0167-6806, 10 p.Article

Survival of breast cancer patients in BRCA1, RBCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from FinlandEEROLA, Hannaleena; VAHTERISTO, Pia; SARANTAUS, Laura et al.International journal of cancer. 2001, Vol 93, Num 3, pp 368-372, issn 0020-7136Article

Mutations N34S and P55S of the SPINK1 gene in patients with chronic pancreatitis or pancreatic cancer and in healthy subjects: A report from FinlandLEMPINEN, Marko; PAJU, Annukka; KEMPPAINEN, Esko et al.Scandinavian journal of gastroenterology. 2005, Vol 40, Num 2, pp 225-230, issn 0036-5521, 6 p.Article

No germline FH mutations in familial breast cancer patientsKIURU, Maija; LEHTONEN, Rainer; EEROLA, Hannaleena et al.European journal of human genetics. 2005, Vol 13, Num 4, pp 506-509, issn 1018-4813, 4 p.Article

Characterization of monoclonal antibodies against prostate specific antigen produced by genetic immunizationLEINONEN, Jari; NIEMELÄ, Pauliina; LÖVGREN, Janita et al.Journal of immunological methods. 2004, Vol 289, Num 1-2, pp 157-167, issn 0022-1759, 11 p.Article

The Breast Cancer Susceptibility Mutation PALB2 1592deIT Is Associated with an Aggressive Tumor PhenotypeHEIKKINEN, Tuomas; KÄRKKÄINEN, Hanni; AALTONEN, Kirsimari et al.Clinical cancer research (Print). 2009, Vol 15, Num 9, pp 3214-3222, issn 1078-0432, 9 p.Article

p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome : Further evidence of CHK2 in inherited cancer predispositionVAHTERISTO, Pia; TAMMINEN, Anitta; KARVINEN, Petteri et al.Cancer research (Baltimore). 2001, Vol 61, Num 15, pp 5718-5722, issn 0008-5472Article

Glycodelin expression associates with differential tumour phenotype and outcome in sporadic and familial non-BRCA1/2 breast cancer patientsHAUTALA, Laura C; GRECO, Dario; KOISTINEN, Riitta et al.Breast cancer research and treatment. 2011, Vol 128, Num 1, pp 85-95, issn 0167-6806, 11 p.Article

Exclusion of large deletions and other rearrangements in BRCA1 and BRCA2 in Finnish breast and ovarian cancer familiesLAHTI-DOMENICI, Jaana; RAPAKKO, Katrin; PÄÄKKÖNEN, Kati et al.Cancer genetics and cytogenetics. 2001, Vol 129, Num 2, pp 120-123, issn 0165-4608Article

A Genome-wide Association Study of Early-Onset Breast Cancer Identifies PFKM as a Novel Breast Cancer Gene and Supports a Common Genetic Spectrum for Breast Cancer at Any AgeAHSAN, Habibul; HALPERN, Jerry; ROY, Shantanu et al.Cancer epidemiology, biomarkers & prevention. 2014, Vol 23, Num 4, pp 658-669, issn 1055-9965, 12 p.Article

Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcomeJAMSHIDI, Maral; SCHMIDT, Marjanka K; FIGUEROA, Jonine et al.International journal of cancer (Print). 2013, Vol 132, Num 9, pp 2044-2055, issn 0020-7136, 12 p.Article

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)MAVADDAT, Nasim; BARROWDALE, Daniel; MULLIGAN, Anna Marie et al.Cancer epidemiology, biomarkers & prevention. 2012, Vol 21, Num 1, pp 134-147, issn 1055-9965, 14 p.Article

Utilization of fluorescence in situ hybridization with cytokeratin discriminators in TOP2A assessment of chemotherapy-treated patients with breast cancerPIERCEALL, William E; SPROTT, Kam M; BARTKOVA, Jirina et al.Human pathology. 2012, Vol 43, Num 9, pp 1363-1375, issn 0046-8177, 13 p.Article

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancerVAHTERISTO, Pia; BARTKOVA, Jirina; HOLLI, Kaija et al.American journal of human genetics. 2002, Vol 71, Num 2, pp 432-438, issn 0002-9297Article

Familial Breast Cancers without Mutations in BRCA1 or BRCA2 Have Low Cyclin E and High Cyclin D1 in Contrast to Cancers in BRCA Mutation CarriersAALTONEN, Kirsimari; BLOMQVIST, Carl; AMINI, Rose-Marie et al.Clinical cancer research. 2008, Vol 14, Num 7, pp 1976-1983, issn 1078-0432, 8 p.Article

Prognostic Role of HuR in Hereditary Breast CancerHEINONEN, Mira; FAGERHOLM, Rainer; AALTONEN, Kirsimari et al.Clinical cancer research. 2007, Vol 13, Num 23, pp 6959-6963, issn 1078-0432, 5 p.Article

NQO1 expression correlates inversely with NFκB activation in human breast cancerJAMSHIDI, Maral; BARTKOVA, Jirina; HEIKKILÄ, Päivi et al.Breast cancer research and treatment. 2012, Vol 132, Num 3, pp 955-968, issn 0167-6806, 14 p.Article

The Retinoblastoma Gene Undergoes Rearrangements in BRCA1-Deficient Basal-like Breast CancerJÖNSSON, Goran; STAAF, Johan; PERSSON, Camilla et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 16, pp 4028-4036, issn 0008-5472, 9 p.Article

Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer riskORR, Nick; LEMNRAU, Alina; MCDADE, Simon S et al.Nature genetics. 2012, Vol 44, Num 11, pp 1182-1184, issn 1061-4036, 3 p.Article

Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 ControlsFLETCHER, Olivia; JOHNSON, Nichola; BARTRAM, Claus R et al.Cancer epidemiology, biomarkers & prevention. 2010, Vol 19, Num 9, pp 2143-2151, issn 1055-9965, 9 p.Article

No evidence that GATA3 rs570613 SNP modifies breast cancer riskJOHNATTY, Sharon E; COUCH, Fergus J; FINK-RETTER, Anneliese et al.Breast cancer research and treatment. 2009, Vol 117, Num 2, pp 371-379, issn 0167-6806, 9 p.Article

NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancerFAGERHOLM, Rainer; HOFSTETTER, Barbara; UUSITUPA, Matti et al.Nature genetics. 2008, Vol 40, Num 7, pp 844-853, issn 1061-4036, 10 p.Article

AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers : A consortium of investigators of modifiers of BRCA1/2 studyCOUCH, Fergus J; SINILNIKOVA, Olga; PEOCK, Susan et al.Cancer epidemiology, biomarkers & prevention. 2007, Vol 16, Num 7, pp 1416-1421, issn 1055-9965, 6 p.Article